dolap 2 mg/1 kapsula kapsula, tvrda
zada pharmaceuticals d.o.o. - trandolapril - kapsula, tvrda - 2 mg/1 kapsula - 1 kapsula, tvrda sadrži: 2 mg trandolapril
enox 1.25 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - ramipril - tableta - 1.25 mg/1 tableta - 1 tableta sadrži:ramipril 1,25 mg
enox 2.5 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - ramipril - tableta - 2.5 mg/1 tableta - 1 tableta sadrži:ramipril 2,5 mg
enox 5 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - ramipril - tableta - 5 mg/1 tableta - 1 tableta sadrži:ramipril 5mg
enox 10 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - ramipril - tableta - 10 mg/1 tableta - 1 tableta sadrži: ramipril 10 mg
ariprexa 10 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - aripiprazol - tableta - 10 mg/1 tableta - 1tableta sadrži: 10 mg aripiprazola
ariprexa 15 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - aripiprazol - tableta - 15 mg/1 tableta - 1tableta sadrži: 15 mg aripiprazola
yanimo respimat 2,5 mikrograma/2,5 mikrograma, otopina inhalata
boehringer ingelheim international gmbh, binger straβe 173, ingelheim am rhein, njemačka - tiotropii bromidum, olodaterolum - otopina inhalata - 2,5 µg/2,5 µg - urbroj: jedna inhalacijska doza sadržava 2,5 mikrograma tiotropija (u obliku bromidhidrata) i 2,5 mikrograma olodaterola (u obliku klorida) po potisku
dovato 50 mg/1 tableta+ 300 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - dolutegravir, lamivudin - filmom obložena tableta - 50 mg/1 tableta+ 300 mg/1 tableta - jedna filmom obložena tableta sadrži: 50 mg dolutegravira (u obliku dolutegravir natrija) i 300 mg lamivudina
bimzelx
ucb pharma s.a. - bimekizumab - psorijaza - imunosupresivi - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.